Li Auto
LI
10.99
+0.10
+0.92%
Li Auto
US · LI
#1386 by market cap
Listed 2020
10.99
+0.10
+0.92%
Live - 5344 symbols - heartbeat 266s ago
· 2026-10-08 06:54
Pre-market
10.95
-0.36%
After-hours
11.04
+0.46%
Overnight
10.88
-1.00%
- Market cap
- 11.33B
- P/E (TTM)i
- -16.31
- P/Bi
- 1.16
- EPSi
- 0.16
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on LI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.30, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -22.25% YoY
Margins
- Gross margin
- 18.68%
- Operating margin
- -0.46%
- Net margin
- 1.00%
Key ratios & quality
- Enterprise valuei
- -78.49B
- Altman Z-Scorei
- 1.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 284.37M | 9.46B | 27.01B | 45.29B | 123.85B | 144.46B | 112.31B |
| Gross profit | 0 | -95.00K | 1.55B | 5.76B | 8.79B | 27.50B | 29.66B | 20.99B |
| Selling & admin expenses | 296.17M | 613.66M | 1.08B | 3.49B | 5.67B | 9.77B | 12.23B | 10.66B |
| Research & development | 793.72M | 1.17B | 1.10B | 3.29B | 6.78B | 10.59B | 11.07B | 11.31B |
| Operating profit | -1.13B | -1.84B | -669.34M | -1.02B | -3.65B | 7.41B | 7.02B | -521.12M |
| Pretax profit | -1.17B | -2.42B | -188.88M | -152.81M | -2.16B | 10.45B | 9.32B | 1.30B |
| Tax | 0 | 0 | -22.85M | 168.64M | -127.01M | -1.36B | 1.27B | 157.71M |
| Net profit | -1.53B | -2.44B | -151.66M | -321.46M | -2.03B | 11.81B | 8.05B | 1.14B |
| Basic EPS | -2 | -4 | -2 | 0 | -2 | 12 | 8 | 1 |
| Diluted EPS | -2.04 | -3.63 | -1.82 | -0.34 | -2.08 | 11.10 | 7.58 | 1.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 25.93B | 30.25B | 27.36B | 28.78B | 22.98B | 25.67B |
| Gross profit | 5.32B | 6.07B | 4.47B | 5.13B | 1.81B | 2.84B |
| Selling & admin expenses | 2.53B | 2.72B | 2.77B | 2.65B | 2.05B | 2.28B |
| Research & development | 2.51B | 2.81B | 2.97B | 3.02B | 2.72B | 2.78B |
| Operating profit | 271.65M | 827.02M | -1.18B | -442.59M | -3.00B | -2.30B |
| Pretax profit | 774.43M | 1.29B | -738.93M | -27.34M | -2.60B | -1.95B |
| Tax | 127.78M | 192.05M | -114.53M | -47.59M | -325.15M | -243.61M |
| Net profit | 646.65M | 1.10B | -624.40M | 20.24M | -2.28B | -1.71B |
| Basic EPS | 1 | 1 | -1 | 0 | -2 | -2 |
| Diluted EPS | 0.62 | 1.02 | -0.62 | 0.00 | -2.26 | -1.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.29B | 5.07B | 31.39B | 52.38B | 66.99B | 114.53B | 126.31B | 115.29B |
| Cash & ST investments | 930.11M | 3.57B | 28.64B | 47.52B | 56.51B | 103.26B | 112.81B | 101.02B |
| Inventory | 155.00K | 518.09M | 1.05B | 1.62B | 6.80B | 6.87B | 8.19B | 8.75B |
| Total assets | 5.78B | 9.51B | 36.37B | 61.85B | 86.54B | 143.47B | 162.35B | 154.30B |
| Total current liabilities | 1.75B | 4.68B | 4.31B | 12.11B | 27.37B | 72.74B | 69.22B | 63.55B |
| Short-term debt | 128.02M | 1.47B | 210.53M | 510.29M | 1.09B | 8.12B | 1.81B | 7.91B |
| Long-term debt | 644.60M | -- | 511.64M | 5.96B | 9.23B | 1.75B | 8.15B | 3.30B |
| Total liabilities | 8,176,715,000.00 | 15,187,953,000.00 | 6,569,679,000.00 | 20,784,611,000.00 | 41,351,644,000.00 | 82,892,249,000.00 | 91,028,696,000.00 | 81,156,075,000.00 |
| Total equity | -2.40B | -5.67B | 29.80B | 41.06B | 45.19B | 60.58B | 71.32B | 73.14B |
| Retained earnings | -2.41B | -5.69B | -6.48B | -6.81B | -8.82B | 2.44B | 10.16B | 11.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 126.17B | 123.54B | 112.75B | 115.29B | 105.60B | 98.47B |
| Cash & ST investments | 110.68B | 106.92B | 98.68B | 101.02B | 93.11B | 85.59B |
| Inventory | 10.09B | 11.73B | 8.23B | 8.75B | 7.03B | 8.33B |
| Total assets | 161.85B | 161.29B | 153.12B | 154.30B | 144.57B | 140.68B |
| Total current liabilities | 67.48B | 71.21B | 62.54B | 63.55B | 56.19B | 54.48B |
| Short-term debt | 1.79B | 8.12B | 7.95B | 7.91B | 7.71B | 1.86B |
| Long-term debt | 8.15B | 1.83B | 3.14B | 3.30B | 3.79B | 6.86B |
| Total liabilities | 89,528,624,000.00 | 87,657,512,000.00 | 79,918,084,000.00 | 81,156,075,000.00 | 73,958,629,000.00 | 74,717,985,000.00 |
| Total equity | 72.33B | 73.63B | 73.20B | 73.14B | 70.61B | 65.96B |
| Retained earnings | -- | -- | -- | 11.18B | -- | 7.18B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.35B | -1.79B | 3.14B | 8.34B | 7.38B | 50.69B | 15.93B | -8.61B |
| Depreciation & amortization | 60.50M | 116.39M | 321.00M | 590.40M | 1.21B | 1.81B | 3.06B | 4.64B |
| Free cash flow | -2.32B | -2.75B | 2.46B | 4.90B | 2.25B | 44.19B | 8.20B | -12.82B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 21.03B | 11.00B | 2.46B | 1.17B | 0 | 0 |
| Ending cash balance | 95.52M | 1.44B | 10.17B | 30.49B | 40.42B | 91.33B | 65.91B | 56.91B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.70B | -3.04B | -7.40B | 3.52B | -6.09B | 15.03M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -1.70B | -3.04B | -7.40B | 950.99M | -6.09B | -2.60B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 53.24B | 49.80B | 51.32B | 56.91B | 42.87B | 40.13B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -104.96 | -4.40 | -0.91 | -4.68 | 22.29 | 12.26 | 1.57 |
| ROA %i | -32.00 | -26.31 | -3.45 | -0.65 | -2.71 | 10.18 | 5.25 | 0.71 |
| ROIC %i | -- | -56.76 | -3.86 | -2.05 | -5.34 | 15.60 | 8.23 | -0.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | 4.48 | 6.11 |
| EBIT margin %i | -- | -820.84 | -1.29 | -0.33 | -4.53 | 8.51 | 6.58 | 1.30 |
| FCF / sales %i | -- | -- | 26.06 | 18.13 | 4.97 | 35.68 | 5.68 | -- |
| Current ratioi | 1.31 | 1.08 | 7.28 | 4.33 | 2.45 | 1.57 | 1.82 | 1.81 |
| Quick ratioi | 1.26 | 0.87 | 6.72 | 3.93 | 2.07 | 1.42 | 1.63 | 1.59 |
| Debt / assetsi | 23.46 | 17.98 | 5.81 | 12.68 | 14.17 | 9.44 | 10.07 | 11.55 |
| LT debt / equityi | -- | -- | 6.39 | 17.85 | 24.92 | 9.02 | 20.50 | 13.64 |
| Interest coveragei | -17.36 | -27.90 | -1.82 | -1.42 | -19.31 | 122.18 | 50.62 | 8.72 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | 442.04 | 135.72 | 74.88 | 35.36 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 161.73 | 18.77 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.15 | 11.88 | -- | 1.57 | -2.56 | -6.66 |
| ROA %i | 5.19 | 5.27 | -- | 0.71 | -1.18 | -3.05 |
| ROIC %i | 8.71 | 8.41 | -- | -0.46 | -3.66 | -6.97 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.65 | 6.80 | -- | 1.30 | -1.75 | -4.86 |
| FCF / sales %i | 6.80 | 3.91 | -- | -- | -- | -- |
| Current ratioi | 1.87 | 1.73 | 1.80 | 1.81 | 1.88 | 1.81 |
| Quick ratioi | 1.64 | 1.50 | 1.58 | 1.59 | 1.66 | 1.57 |
| Debt / assetsi | 10.11 | 10.49 | 11.69 | 11.55 | 12.27 | 10.44 |
| LT debt / equityi | 20.27 | 12.02 | 13.68 | 13.64 | 14.31 | 19.61 |
| Interest coveragei | 46.40 | 45.53 | -- | 8.72 | -11.95 | -22.42 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:54:27 · For reference only, not investment advice and not tailored to your situation.